Lars Buschhorn

461 total citations
11 papers, 271 citations indexed

About

Lars Buschhorn is a scholar working on Cancer Research, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lars Buschhorn has authored 11 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 5 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lars Buschhorn's work include Cancer Genomics and Diagnostics (7 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Lars Buschhorn is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Lars Buschhorn collaborates with scholars based in Germany, United States and Austria. Lars Buschhorn's co-authors include Adam Wahida, Andreas Schneeweiß, Philipp J. Jost, Razelle Kurzrock, Vivek Subbiah, Peter Lichter, Stefan Fröhling, Mohamed A. Gouda, Blessie Elizabeth Nelson and Giuseppe Curigliano and has published in prestigious journals such as Nature Medicine, Nature reviews. Cancer and Cancer Research.

In The Last Decade

Lars Buschhorn

9 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Buschhorn Germany 5 114 105 102 79 29 11 271
Feiteng Lu China 12 77 0.7× 118 1.1× 102 1.0× 57 0.7× 14 0.5× 21 306
Susanne Beck Germany 8 57 0.5× 115 1.1× 123 1.2× 47 0.6× 40 1.4× 19 236
Christoforos Vaxevanis Germany 9 73 0.6× 83 0.8× 169 1.7× 45 0.6× 24 0.8× 17 311
Murtuza Rampurwala United States 10 80 0.7× 84 0.8× 161 1.6× 71 0.9× 15 0.5× 28 266
Joshua F. Coleman United States 9 60 0.5× 96 0.9× 139 1.4× 33 0.4× 31 1.1× 18 274
Kristen N. Cordova United States 4 79 0.7× 153 1.5× 85 0.8× 75 0.9× 23 0.8× 5 413
Zuyi Yang China 10 125 1.1× 184 1.8× 119 1.2× 167 2.1× 12 0.4× 20 350
Li-Na Zhou China 10 63 0.6× 202 1.9× 191 1.9× 70 0.9× 19 0.7× 20 405
Matteo Repetto Italy 10 114 1.0× 131 1.2× 159 1.6× 126 1.6× 9 0.3× 23 360
Danmei Pang China 7 113 1.0× 117 1.1× 196 1.9× 151 1.9× 10 0.3× 17 357

Countries citing papers authored by Lars Buschhorn

Since Specialization
Citations

This map shows the geographic impact of Lars Buschhorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Buschhorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Buschhorn more than expected).

Fields of papers citing papers by Lars Buschhorn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Buschhorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Buschhorn. The network helps show where Lars Buschhorn may publish in the future.

Co-authorship network of co-authors of Lars Buschhorn

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Buschhorn. A scholar is included among the top collaborators of Lars Buschhorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Buschhorn. Lars Buschhorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Subbiah, Vivek, Giuseppe Curigliano, Jason K. Sicklick, et al.. (2025). Cancer treatment paradigms in the precision medicine era. Nature Medicine. 31(11). 3609–3611. 3 indexed citations
2.
Kairemo, Kalevi, Mohamed A. Gouda, Lars Buschhorn, et al.. (2023). Sodium fluoride (Na18F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumors. ESMO Open. 8(4). 101575–101575. 1 indexed citations
3.
Gouda, Mohamed A., Blessie Elizabeth Nelson, Lars Buschhorn, Adam Wahida, & Vivek Subbiah. (2023). Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications. Clinical Cancer Research. 29(15). 2753–2760. 38 indexed citations
4.
Gouda, Mohamed A., Lars Buschhorn, Andreas Schneeweiß, Adam Wahida, & Vivek Subbiah. (2023). N-of-1 Trials in Cancer Drug Development. Cancer Discovery. 13(6). 1301–1309. 22 indexed citations
5.
Schneeweiß, Andreas & Lars Buschhorn. (2023). „Breast-like cancer of unknown primary“. Die Radiologie. 63(5). 366–370.
6.
Schulze, Markus, Lars Buschhorn, Andreas Möck, et al.. (2023). Reimbursement in the Context of Precision Oncology Approaches in Metastatic Breast Cancer: Challenges and Experiences. Breast Care. 19(1). 10–17. 1 indexed citations
7.
Gouda, Mohamed A., Filip Jankú, Adam Wahida, et al.. (2023). Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST). Annals of Oncology. 35(3). 267–275. 50 indexed citations
8.
Gouda, Mohamed A., Blessie Elizabeth Nelson, Lars Buschhorn, Adam Wahida, & Vivek Subbiah. (2023). Abstract 1173: Landscape of 4,506 pan-cancer samples harboring BRAFV600E mutations, and NTRK/RET Fusions from 137,401 adult patients with cancer: Clinical implications for tissue agnostic therapies. Cancer Research. 83(7_Supplement). 1173–1173.
9.
Wahida, Adam, Lars Buschhorn, Stefan Fröhling, et al.. (2022). The coming decade in precision oncology: six riddles. Nature reviews. Cancer. 23(1). 43–54. 121 indexed citations
10.
Buschhorn, Lars, Veronika Dill, Khalid Shoumariyeh, et al.. (2021). Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies. Journal of Cancer Research and Clinical Oncology. 148(2). 331–340. 3 indexed citations
11.
Jilg, Stefanie, Lars Buschhorn, Veronika Dill, et al.. (2019). Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose. Experimental Hematology and Oncology. 8(1). 9–9. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feiteng Lu Breakdown of academic impact, for papers by Susanne Beck Breakdown of academic impact, for papers by Christoforos Vaxevanis Breakdown of academic impact, for papers by Murtuza Rampurwala Breakdown of academic impact, for papers by Joshua F. Coleman Breakdown of academic impact, for papers by Kristen N. Cordova Breakdown of academic impact, for papers by Zuyi Yang Breakdown of academic impact, for papers by Li-Na Zhou Breakdown of academic impact, for papers by Matteo Repetto Breakdown of academic impact, for papers by Danmei Pang
Rankless by CCL
2026